Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
ChemMedChem ; 12(12): 913-916, 2017 06 21.
Article in English | MEDLINE | ID: mdl-28342294

ABSTRACT

Herein we describe the drug design steps developed to increase the radical scavenging and ß-amyloid aggregation inhibitory activities of a previously described series of benzylidenephenylpyrrolizinones. Among the newly synthesized derivatives, some benzylphenylpyrrolizinones exhibited interesting results in regard to those activities. Initial druggability parameters were measured, and suggest these compounds as a suitable starting point for potential alternatives in treating Alzheimer's disease.


Subject(s)
Adrenergic alpha-2 Receptor Antagonists/pharmacology , Alzheimer Disease/drug therapy , Amyloid beta-Peptides/antagonists & inhibitors , Free Radical Scavengers/pharmacology , Pyrrolizidine Alkaloids/pharmacology , Adrenergic alpha-2 Receptor Antagonists/chemical synthesis , Adrenergic alpha-2 Receptor Antagonists/chemistry , Dose-Response Relationship, Drug , Drug Design , Free Radical Scavengers/chemical synthesis , Free Radical Scavengers/chemistry , Humans , Models, Molecular , Molecular Structure , Protein Aggregates/drug effects , Pyrrolizidine Alkaloids/chemical synthesis , Pyrrolizidine Alkaloids/chemistry , Structure-Activity Relationship
2.
Eur J Med Chem ; 114: 365-79, 2016 May 23.
Article in English | MEDLINE | ID: mdl-27046230

ABSTRACT

This work describes the synthesis and the biological evaluation of novel benzylidenephenylpyrrolizinones as potential antioxidant, metal chelating or amyloid ß (ßA) aggregation inhibitors. Some derivatives exhibited interesting results in regard to several of the performed evaluations and appear as valuable Multi-Target Directed Ligands with potential therapeutic interest in Alzheimer's disease. Among them, compound 29 particularly appears as a valuable radical and NO scavenger, a Cu(II) and Fe(II) chelating agent and exhibits moderate ßA aggregation inhibition properties. These activities, associated to a good predictive bioavailability and a lack of cytotoxicity, design it as a promising hit for further in vivo investigation.


Subject(s)
Alzheimer Disease/drug therapy , Amyloid beta-Peptides/metabolism , Antioxidants/pharmacology , Benzyl Compounds/pharmacology , Protein Aggregates/drug effects , Pyrroles/pharmacology , Alzheimer Disease/metabolism , Antioxidants/chemical synthesis , Antioxidants/chemistry , Benzyl Compounds/chemical synthesis , Benzyl Compounds/chemistry , Cell Proliferation , Dose-Response Relationship, Drug , Humans , KB Cells , Models, Molecular , Molecular Structure , Protein Binding/drug effects , Pyrroles/chemical synthesis , Pyrroles/chemistry , Structure-Activity Relationship , Tumor Cells, Cultured
3.
Eur J Med Chem ; 86: 279-90, 2014 Oct 30.
Article in English | MEDLINE | ID: mdl-25173827

ABSTRACT

We previously reported that the cinnamylpiperazinyl group in the side chain of the chenodeoxycholic acid showed apoptosis-inducing activity on multiple myeloma cancer cell line KMS-11. In the present study, we synthesized and tested the pro-apoptotic potency of fifteen new piperazinyl bile carboxamide derived from cholic, ursodeoxycholic, chenodeoxycholic, deoxycholic and lithocholic acids on human colon adenocarcinoma cell lines DLD-1, HCT-116, and HT-29. Cell viability was first measured using XTT assay. The most of the synthetic bile carboxamide derivatives decreased significantly cell viability in a dose-dependent manner. HCT-116 and DLD-1 cell lines were more sensitive than HT-29 to tested compounds. 9c, 9d showed the best in vitro results in term of solubility and dose-response effect on the three colon adenocarcinoma cell lines. Additionally, flow cytometric and Western-blotting analysis showed that 9c induced pro-apoptosis in DLD-1 and HCT-116 whereas 9d did not. We conclude that the benzyl group improved anti-proliferative activity and that the α-hydroxyl group was found to be more beneficial at the 7-position in steroid skeleton.


Subject(s)
Adenocarcinoma/drug therapy , Amides/pharmacology , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Bile Acids and Salts/pharmacology , Colonic Neoplasms/drug therapy , Adenocarcinoma/pathology , Amides/chemical synthesis , Amides/chemistry , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Bile Acids and Salts/chemical synthesis , Bile Acids and Salts/chemistry , Cell Cycle/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Colonic Neoplasms/pathology , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , HCT116 Cells , HT29 Cells , Humans , Molecular Structure , Structure-Activity Relationship , Tumor Cells, Cultured
4.
Chem Biol Drug Des ; 82(5): 620-9, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23906044

ABSTRACT

Nine new 17-(piperazin-1-yl)pyridin-5-yl)steroids as abiraterone analogues were synthesized. Compounds 5d and 5g showed selective activities against 17α-hydroxylase/C17,20-lyase (CYP17A1) and aromatase (CYP19), respectively. IC50 values of 5d were 5.09 and >50 µm, whereas these values for 5g were >50 µm and 7.40 µm, respectively, for CYP17A1 and CYP19. Molecular modelling highlighted that the inhibitor designed to bind cytochrome P450 haem iron is a necessary condition but not the only rationale to explain inhibitory activity. These abiraterone analogues were then evaluated on hormone-independent prostate cancer cell lines DU-145 and PC-3 and on hormone-dependent breast and prostate cancer cell lines MCF-7 and LNCaP, respectively. Compounds 5e, 5g and 5i have showed potent activities only on hormone-independent prostate cancer cell lines DU-145 and PC-3 with 60-85% inhibition of both cell viability and growth at 10 nm with pro-apoptotic mechanism as illustrated in PC-3 cells by DNA ladder assay and Western blotting of Bax, Casp-3 and its substrate, the poly (ADP-ribose) polymerase. We conclude that hybrid heterocycle steroids could be good lead compounds in the drug design especially against hormone-independent prostate cancer.


Subject(s)
Androstenols/chemistry , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Steroids/chemistry , Steroids/pharmacology , Androstenes , Androstenols/chemical synthesis , Androstenols/pharmacology , Antineoplastic Agents/chemical synthesis , Aromatase/chemistry , Aromatase/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , DNA Cleavage/drug effects , Humans , MCF-7 Cells , Male , Piperazines/chemistry , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/pathology , Pyridines/chemistry , Steroid 17-alpha-Hydroxylase/antagonists & inhibitors , Steroid 17-alpha-Hydroxylase/metabolism , Steroids/chemical synthesis
5.
Steroids ; 77(1-2): 10-26, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22037250

ABSTRACT

Dehydroepiandrosterone (DHEA) is a multifunctional steroid with a broad range of biological effects in humans and animals. DHEA can be converted to multiple oxygenated metabolites in the brain and peripheral tissues. The mechanisms by which DHEA exerts its effects are not well understood. However, evidence that the effects of DHEA are mediated by its oxygenated metabolites has accumulated. This paper will review the panel of oxygenated DHEA metabolites (7, 16 and 17-hydroxylated derivatives) including a number of 5α-androstane derivatives, such as epiandrosterone (EpiA) metabolites. The most important aspects of the oxidative metabolism of DHEA in the liver, intestine and brain are described. Then, this article reviews the reported biological effects of oxygenated DHEA metabolites from recent findings with a specific focus on cancer, inflammatory and immune processes, osteoporosis, thermogenesis, adipogenesis, the cardiovascular system, the brain and the estrogen and androgen receptors.


Subject(s)
Androsterone/metabolism , Brain/metabolism , Dehydroepiandrosterone/metabolism , Intestinal Mucosa/metabolism , Liver/metabolism , Androsterone/analogs & derivatives , Animals , Cardiovascular Diseases/metabolism , Cardiovascular Diseases/physiopathology , Dehydroepiandrosterone/analogs & derivatives , Female , Humans , Hydroxylation , Inflammation/metabolism , Inflammation/physiopathology , Male , Mice , Neoplasms/metabolism , Neoplasms/physiopathology , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/physiopathology , Osteoporosis/metabolism , Osteoporosis/physiopathology , Oxidation-Reduction , Rabbits , Rats , Reactive Oxygen Species/metabolism , Receptors, Androgen/metabolism , Receptors, Estrogen/metabolism
6.
Eur J Med Chem ; 45(7): 2912-8, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20381215

ABSTRACT

The novelty of this work derives from the use of nitrogenous heterocycles as building block in the synthesis of conjugate bile acid derivatives. New piperazinyl bile acid derivatives were synthesized and tested in vitro against various human cancer cells (GBM, KMS-11, HCT-116). The best pro-apoptotic activity was obtained with N-[4N-cinnamylpiperazin-1-yl)-3alpha,7beta-dihydroxy-5beta-cholan-24-amide (7b) and N-[4N-cinnamyllpiperazin-1-yl)- 3alpha,7alpha-dihydroxy-5beta-cholan-24-amide (7c) on these human cancer cell lines (IC(50): 8.5-31.4microM). This activity was associated with nuclear and DNA fragmentation, demonstrating that 7b induces cell death by an apoptotic process as 7c. This study shows the possibility of hydrid heterocycle-steroids as new anticancer agents with improved bioactivity and easy to synthesize.


Subject(s)
Apoptosis/drug effects , Bile Acids and Salts/chemical synthesis , Bile Acids and Salts/pharmacology , Colonic Neoplasms/pathology , Glioblastoma/pathology , Multiple Myeloma/pathology , Bile Acids and Salts/chemistry , Cell Line, Tumor , Humans , Piperazine , Piperazines/chemistry
7.
Steroids ; 74(12): 931-7, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19577585

ABSTRACT

Neurosteroids have been reported to modulate memory processes in rodents. Three analogues of dehydroepiandrosterone (DHEA), two of them previously described (7beta-aminoDHEA and 7beta-amino-17-ethylenedioxy-DHEA), and a new one (3beta-hydroxy-5alpha-androstane-6,17-dione) were synthesized, and their effects were evaluated on memory. This study examined their effects on long term and short term memory in male (6 weeks old) NMRI mice in comparison with the reference drug. Long term memory was assessed using the passive avoidance task and short term memory (spatial working memory) using the spontaneous alternation task in a Y maze. Moreover, the effects of DHEA and its analogues on spontaneous locomotion were measured. In all tests, DHEA and analogues were injected at three equimolar doses (0.300-1.350-6.075 microM/kg). DHEA and its three analogues administered immediately post-training at the highest doses (6.075 microM/kg, s.c.) improved retention in passive avoidance test. Without effect per se in the spatial working memory task, the four compounds failed to reverse scopolamine (1mg/kg, i.p.)-induced deficit in spontaneous alternation. These data suggested an action of DHEA and analogues in consolidation of long term memory particularly when emotional components are implied. Moreover, data indicated that pharmacological modulation of DHEA as performed in this study provides derivatives giving the same mnemonic profile than reference molecule.


Subject(s)
Dehydroepiandrosterone/analogs & derivatives , Dehydroepiandrosterone/pharmacology , Etiocholanolone/analogs & derivatives , Memory/drug effects , Memory/physiology , Amnesia/chemically induced , Amnesia/drug therapy , Amnesia/physiopathology , Animals , Behavior, Animal/drug effects , Dehydroepiandrosterone/chemistry , Dehydroepiandrosterone/therapeutic use , Etiocholanolone/pharmacology , Etiocholanolone/therapeutic use , Male , Memory, Short-Term/drug effects , Memory, Short-Term/physiology , Mice , Motor Activity/drug effects , Scopolamine/pharmacology
8.
Acta Crystallogr C ; 65(Pt 7): o311-3, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19578262

ABSTRACT

The stilbene derivative 1,2,3-trimethoxy-4-[(E)-2-phenylvinyl]benzene, C(17)H(18)O(3), (I), and its homocoupling co-product (E,E)-1,4-bis(2,3,4-trimethoxyphenyl)buta-1,3-diene, C(22)H(26)O(6), (II), both have double bonds in trans conformations in their conjugated linkages. In the structure of stilbene (I), the aromatic rings deviate significantly from coplanarity, in contrast with coproduct (II), the core of which is rigorously planar. The deviation in stilbene (I) seems to be driven by intermolecular electrostatic interactions. Diene (II) sits on a crystallographic inversion centre, which bisects the conjugated linkage.


Subject(s)
Alkadienes/chemistry , Butadienes/chemistry , Stilbenes/chemistry , Vinyl Compounds/chemistry , Crystallography, X-Ray , Molecular Conformation
9.
Bioorg Med Chem ; 16(18): 8737-44, 2008 Sep 15.
Article in English | MEDLINE | ID: mdl-18768321

ABSTRACT

Six new synthetic bile acid derivatives were synthesized and tested in vitro against various human cancer cells (glioblastoma multiforme (GBM), multiple myeloma (KMS-11), and colonic carcinoma (HCT-116) cell lines. The best activity was obtained with compound IIIb on multiple myeloma cells (LD(50): 8.5+/-0.5 microM). This activity was associated with Mcl-1 and PARP-1 cleavage, inhibition of NFkappaB signaling, and DNA fragmentation, demonstrating an apoptotic cell death signaling pathway.


Subject(s)
Amides/pharmacology , Apoptosis/drug effects , Cell Proliferation/drug effects , Chenodeoxycholic Acid/pharmacology , Lithocholic Acid/pharmacology , Neoplasms , Piperazines/pharmacology , Amides/chemical synthesis , Blotting, Western , Cell Line, Tumor , Chenodeoxycholic Acid/analogs & derivatives , Chenodeoxycholic Acid/chemical synthesis , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , DNA Fragmentation , Glioblastoma/metabolism , Glioblastoma/pathology , Humans , Lithocholic Acid/analogs & derivatives , Lithocholic Acid/chemical synthesis , Multiple Myeloma/metabolism , Multiple Myeloma/pathology , NF-kappa B/antagonists & inhibitors , NF-kappa B/genetics , NF-kappa B/metabolism , Neoplasms/metabolism , Neoplasms/pathology , Piperazines/chemical synthesis , Signal Transduction
10.
Bioorg Med Chem ; 15(9): 3152-60, 2007 May 01.
Article in English | MEDLINE | ID: mdl-17350845

ABSTRACT

Efficient syntheses of new DHEA analogues, and their apoptotic and necrotic effects on Leydig cells and TM4 Sertoli cells are described. The key step in the synthetic strategy of 7-amino-DHEA derivatives involves a bromination on C-7 position to give an epimeric mixture of bromides which were substituted by azides and reduced to give 7alpha- and 7beta-amino-3beta-hydroxyandrost-5-en-17-ones. No cytotoxic effect induced by apoptosis mechanism was observed on Leydig and TM4 Sertoli cells by treatment with these amino-DHEA analogues. A necrotic effect was induced only in TM4 Sertoli cells. The best activity was obtained with 7alpha,beta-amino-androst-5-en-3beta-ol and 7beta-amino-3beta-hydroxy-androst-5-en-17-one.


Subject(s)
Dehydroepiandrosterone/analogs & derivatives , Dehydroepiandrosterone/chemical synthesis , Dehydroepiandrosterone/toxicity , Leydig Cells/drug effects , Sertoli Cells/drug effects , Animals , Cell Survival/drug effects , Cells, Cultured , Dehydroepiandrosterone/chemistry , Dose-Response Relationship, Drug , Male , Molecular Conformation , Rats , Rats, Sprague-Dawley , Stereoisomerism , Structure-Activity Relationship
11.
Eur J Med Chem ; 41(10): 1109-16, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16949702

ABSTRACT

Two sterol families have been synthesized: the first one is nitrogenous sterols containing amino, N-hydroxyimino or cyano group and the second one is oxysterols such as ketosterol and hydroxysterols. These compounds were then evaluated in vitro against Leishmania donovani promastigotes and Trypanosoma brucei brucei trypomastigotes. The most active compounds against L. donovani promastigotes were 7beta-aminomethylcholesterol and 7alpha,beta-aminocholesterol (IC50 in a range from 1 to 3 microM, pentamidine: 2.8 microM). These compounds were active on intramacrophage amastigotes with IC50 of 1.3 microM. Such an activity justifies further in vivo antileishmanial evaluation. Against T. b. brucei, (24R,S)-24-hydroxy-24-methylcholesterol (MEC, 12.5 microM) was the most active compound from these series.


Subject(s)
Antiprotozoal Agents , Leishmania donovani/drug effects , Steroids , Trypanocidal Agents , Trypanosoma brucei brucei/drug effects , Animals , Antiprotozoal Agents/chemical synthesis , Antiprotozoal Agents/chemistry , Antiprotozoal Agents/pharmacology , Cells, Cultured , Female , Leishmania donovani/classification , Macrophages/parasitology , Mice , Molecular Structure , Parasitic Sensitivity Tests , Stereoisomerism , Steroids/chemical synthesis , Steroids/chemistry , Steroids/pharmacology , Structure-Activity Relationship , Trypanocidal Agents/chemical synthesis , Trypanocidal Agents/chemistry , Trypanocidal Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...